Gender difference in rat aorta vasodilation after acute exposure to high glucose: Involvement of protein kinase C β and superoxide but not of Rho Kinase

Cardiovascular Research

Volumn 76, Issue 2, 2007, Pages 351-360

  Goel, Aditya ^a   Zhang, Yingmin ^a   Anderson, Leigh ^b   Rahimian, Roshanak ^a  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Diabetes; Endothelial function; Gender; Nitric oxide; Protein kinase C

Indexed keywords

3 [8 [(DIMETHYLAMINO)METHYL] 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL] 4 (1 METHYL 1H INDOL 3 YL) 1H PYRROLE 2,5 DIONE; ACETYLCHOLINE; ENDOTHELIUM DERIVED RELAXING FACTOR; FASUDIL; GLUCOSE; LY 379196; PHENYLEPHRINE; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA INHIBITOR; RHO KINASE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; EXPOSURE; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SPRAGUE DAWLEY RAT; VASODILATATION; WESTERN BLOTTING;

ACETYLCHOLINE; ANIMALS; BRADYKININ; FEMALE; HYPERGLYCEMIA; MALE; NITROPRUSSIDE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES; SEX CHARACTERISTICS; SUPEROXIDES; VASODILATION;

EID: 36649006862     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.06.029     Document Type: Article

References (33)

1. de Vegt F., Dekker J.M., Ruhe H.G., Stehouwer C.D., Nijpels G., Bouter L.M., et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42 (1999) 926-931
2. Group D.S. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161 (2001) 397-405
3. Steinberg H.O., Paradisi G., Cronin J., Crowde K., Hempfling A., Hook G., et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 101 (2000) 2040-2046
4. Stettler C., Allemann S., Juni P., Cull C.A., Holman R.R., Egger M., et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J 152 (2006) 27-38
5. Hu G. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 46 (2003) 608-617
6. Onat A., Hergenc G., Keles I., Dogan Y., Turkmen S., and Sansoy V. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome. Metabolism 54 (2005) 800-808
7. Janghorbani M., Jones R.B., Gilmour W.H., Hedley A.J., and Zhianpour M. A prospective population based study of gender differential in mortality from cardiovascular disease and "all causes" in asymptomatic hyperglycaemics. J Clin Epidemiol 47 (1994) 397-405
8. Kannel W.B. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 114 (1987) 413-419
9. Di Carli M.F., Afonso L., Campisi R., Ramappa P., Bianco-Batlles D., Grunberger G., et al. Coronary vascular dysfunction in premenopausal women with diabetes mellitus. Am Heart J 144 (2002) 711-718
10. Inoguchi T., Battan R., Handler E., Sportsman J.R., Heath W., and King G.L. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A 89 (1992) 11059-11063
11. Guo M., Wu M.H., Korompai F., and Yuan S.Y. Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes. Physiol Genomics 12 (2003) 139-146
12. Inoguchi T., Li P., Umeda F., Yu H.Y., Kakimoto M., Imamura M., et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49 (2000) 1939-1945
13. Beckman J.A., Goldfine A.B., Gordon M.B., Garrett L.A., and Creager M.A. Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res 90 (2002) 107-111
14. Nangle M.R., Cotter M.A., and Cameron N.E. Protein kinase C beta inhibition and aorta and corpus cavernosum function in streptozotocin-diabetic mice. Eur J Pharmacol 475 (2003) 99-106
15. Cotter M.A., Jack A.M., and Cameron N.E. Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes. Clin Sci (Lond) 103 (2002) 311-321
16. Maeda T., and Lloyd R.V. Protein kinase C activity and messenger RNA modulation by estrogen in normal and neoplastic rat pituitary tissue. Lab Invest 68 (1993) 472-480
17. Karp G., Maissel A., and Livneh E. Hormonal regulation of PKC: Estrogen up-regulates PKCeta expression in estrogen-responsive breast cancer cells. Cancer Lett 246 (2007) 173-181
18. Peters C.A., Cutler R.E., Maizels E.T., Robertson M.C., Shiu R.P., Fields P., et al. Regulation of PKC delta expression by estrogen and rat placental lactogen-1 in luteinized rat ovarian granulosa cells. Mol Cell Endocrinol 162 (2000) 181-191
19. Eto M., Barandier C., Rathgeb L., Kozai T., Joch H., Yang Z., et al. Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase. Circ Res 89 (2001) 583-590
20. Ming X.F., Viswambharan H., Barandier C., Ruffieux J., Kaibuchi K., Rusconi S., et al. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol 22 (2002) 8467-8477
21. Wilkinson S.E., Parker P.J., and Nixon J.S. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 294 Pt 2 (1993) 335-337
22. Gschwendt M., Muller H.J., Kielbassa K., Zang R., Kittstein W., Rincke G., et al. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199 (1994) 93-98
23. Lagaud G.J., Masih-Khan E., Kai S., van Breemen C., and Dube G.P. Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries. J Vasc Res 38 (2001) 578-589
24. Zhang Y.M., Bo J., Taffet G.E., Chang J., Shi J., Reddy A.K., et al. Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis. FASEB J 20 (2006) 916-925
25. Giugliano D., Marfella R., Coppola L., Verrazzo G., Acampora R., Giunta R., et al. Vascular effects of acute hyperglycemia in humans are reversed by l-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 95 (1997) 1783-1790
26. Wang S.X., Xiong X.M., Song T., and Liu L.Y. Protective effects of cariporide on endothelial dysfunction induced by high glucose. Acta Pharmacol Sin 26 (2005) 329-333
27. Bohlen H.G., and Nase G.P. Obesity lowers hyperglycemic threshold for impaired in vivo endothelial nitric oxide function. Am J Physiol Heart Circ Physiol 283 (2002) H391-H397
28. Lott M.E., Hogeman C., Herr M., Gabbay R., and Sinoway L.I. Effects of an oral glucose tolerance test on the myogenic response in healthy individuals. Am J Physiol Heart Circ Physiol 292 (2007) H304-H310
29. Johnstone M.T., Creager S.J., Scales K.M., Cusco J.A., Lee B.K., and Creager M.A. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88 (1993) 2510-2516
30. Rahimian R., Dube G.P., Toma W., Dos Santos N., McManus B.M., and van Breemen C. Raloxifene enhances nitric oxide release in rat aorta via increasing endothelial nitric oxide mRNA expression. Eur J Pharmacol 434 (2002) 141-149
31. Rahimian R., Laher I., Dube G., and van Breemen C. Estrogen and selective estrogen receptor modulator LY117018 enhance release of nitric oxide in rat aorta. J Pharmacol Exp Ther 283 (1997) 116-122
32. Wolfrum S., Dendorfer A., Rikitake Y., Stalker T.J., Gong Y., Scalia R., et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 24 (2004) 1842-1847
33. Rikitake Y., and Liao J.K. Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells. Circulation 111 (2005) 3261-3268